SYNERGIE GENE+ RISK PROTECTION Trademark

Trademark Overview

On Friday, June 23, 2023, a trademark application was filed for SYNERGIE GENE+ RISK PROTECTION with the United States Patent and Trademark Office. The USPTO has given the SYNERGIE GENE+ RISK PROTECTION trademark a serial number of 98055826. The federal status of this trademark filing is REGISTERED as of Tuesday, January 7, 2025. This trademark is owned by Synergie Medication Collective, LLC. The SYNERGIE GENE+ RISK PROTECTION trademark is filed in the Insurance & Financial Services category with the following description:

Development of insurance policies for others for fully insured and self-insured payers specific to the cost of gene therapies to cover costs of gene therapy treatment
synergie gene+ risk protection

General Information

Serial Number98055826
Word MarkSYNERGIE GENE+ RISK PROTECTION
Filing DateFriday, June 23, 2023
Status700 - REGISTERED
Status DateTuesday, January 7, 2025
Registration Number7645617
Registration DateTuesday, January 7, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements

Pseudo MarkSYNERGY GENE AND RISK PROTECTION; SYNERGY GENE PLUS RISK PROTECTION
Goods and ServicesDevelopment of insurance policies for others for fully insured and self-insured payers specific to the cost of gene therapies to cover costs of gene therapy treatment
NOT AVAILABLE"RISK PROTECTION"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, July 25, 2023
Primary Code036
First Use Anywhere DateFriday, December 15, 2023
First Use In Commerce DateFriday, December 15, 2023

Trademark Owner History

Party NameSynergie Medication Collective, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801
Party NameSynergie Medication Collective, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801
Party NameSynergie Medication Collective, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801

Trademark Events

Event DateEvent Description
Tuesday, June 27, 2023NEW APPLICATION ENTERED
Tuesday, July 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Tuesday, September 26, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 26, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Friday, December 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 16, 2024USE AMENDMENT FILED
Monday, September 16, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, November 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, November 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 7, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, December 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

protection risk gene synergie insured cover therapies costs treatment therapy cost payers policies